| [1] |
Durand ML, Endophthalmitis[J]. Clin Microbiol Infect, 2013, 19(3): 227-234.
|
| [2] |
Durand ML, Miller JW, Young LH. Endophthalmitis: An Overview[M]. Switzerland: Springer International Publishing, 2016: 1-16.
|
| [3] |
Ness T, Pelz K, Hansen LL. Endogenous endophthalmitis: microorganisms, disposition and prognosis[J]. Acta Ophthalmol Scand, 2010, 85(8): 852-856.
|
| [4] |
Chee YE, Eliott D. The role of vitrectomy in the management of fungal Endophthalmitis [J]. Semin Ophthalmol, 2017, 32: 29-35.
|
| [5] |
Lupia T, Corcione S, Fea AM, et al. Exogenous fungal endophthalmitis: clues to aspergillus aetiology with a pharmaco-logical perspective[J]. Microorganisms, 2020, 9(1): 74-85.
|
| [6] |
Lim HW, Shin JW, Cho HY, et al. Endogenous endophthalmitis in the Korean population: a six-year retrospective study[J]. Retina, 2014, 34(3): 592-602.
|
| [7] |
Ratra D, Saurabh K, Das D, et al. Endogenous endophthalmitis: A 10-year retrospective study at a tertiary hospital in South India[J]. Asia Pac J Ophthalmol, 2015, 4(5): 286-292.
|
| [8] |
Connell PP, O′Neill EC, Fabinyi D, et al. Endogenous endo-phthalmitis: 10-year experience at a tertiary referral centre[J]. Eye, 2011, 25(1): 66-72.
|
| [9] |
Shen X, Xu G. Vitrectomy for endogenous fungal endophthalmitis[J]. Ocul Immunol Inflamm, 2009, 17(3): 148-152.
|
| [10] |
王文吉. 内源性真菌性眼内炎[J]. 中国眼耳鼻喉科杂志，2018，18(2): 82-85.
|
| [11] |
Chhablani J. Fungal endophthalmitis[J]. Expert Rev Anti infect Ther, 2011, 9(12): 1191-1201.
|
| [12] |
Chen KJ, Wu WC, Sun MH, et al. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes[J]. Am J Ophthalmol, 2012, 154(1): 213-214.
|
| [13] |
Sridhar J, Flynn HW, Kuriyan AE, et al. Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections[J]. J Ophthalmic Inflamm Infect, 2013, 3(1): 60-66.
|
| [14] |
Mirzania D, Fleming TL, Robbins CB, et al. Time to presentation after symptom onset in endophthalmitis: clinical features and visual outcomes[J]. Ophthalmol Retina, 2020, 5(4): 324-329.
|
| [15] |
Chakrabarti A, Shivaprakash MR, Singh R, et al. Fungal endophthalmitis: fourteen years′ experience from a center in India[J]. Retina, 2008, 28(10): 1400-1407.
|
| [16] |
林晓峰，袁敏而. 重视真菌性眼内炎诊疗规范性[J]. 中华实验眼科杂志，2019，37(5)：321-325.
|
| [17] |
Binder MI, Chua J, Kaiser PK, et al. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center[J]. Medicine, 2003, 82(2): 97.
|
| [18] |
张艳琼，王文吉. 内源性眼内炎10年临床回顾性分析[J]. 中华实验眼科杂志，2006，24(1)：91-92.
|
| [19] |
Durand ML. Bacterial and fungal endophthalmitis[J]. Clin Microbio Rev, 2017, 30(3): 597-613.
|
| [20] |
Nagao M, Saito T, Doi S, et al. Clinical characteristics and risk factors of ocular candidiasis[J]. Diag Microbio Infect Dis, 2012, 73(2): 149-152.
|
| [21] |
Adam CR, Sigler EJ. Multimodal imaging findings in endogenous aspergillus endophthalmitis[J]. Retina (Phil), 2014, 34(9): 1914-1915.
|
| [22] |
Rao NA, Hidayat AA. Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis[J]. Am J Ophthalmol, 2001, 132(2): 244-251.
|
| [23] |
Ishibashi Y. Proposed classification of stages of endogenous fungal endophthalmitis[J]. Jpn J Clin Ophthalmol, 1993, 47: 845-849.
|
| [24] |
Chen L, Tao Y, Hu X. Utility of intraocular fluid β-D-glucan testing in fungal endophthalmitis: a series of 5 cases[J]. Am J Case Rep, 2020, 21: e921188.
|
| [25] |
刘瑄，陶勇. 用好眼内液检测[J/CD]. 中华眼科医学杂志(电子版)，2018，8(5)：193-201.
|
| [26] |
Jangam SS, Ingole SN, Deshpande MD, et al. Solitary intraosseous neurofibroma: Report of a unique case [J]. Contemp Clin Dent, 2014, 5(4): 561-563.
|
| [27] |
Samiy N, D′Amico DJ. Endogenous fungal endophthalmitis [J]. Int Ophthalmol Clin, 1996, 36(3): 147-162.
|
| [28] |
Sims CR, Jaijakul S, Mohr J, et al. Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis[J]. J Clin Microbiol, 2012, 50(6): 2104-2106.
|
| [29] |
Ammar MJ, Carroll R, Kolomeyer A, et al. Clinical utility of beta-D-glucan testing for endogenous fungal chorioretinitis or endophthalmitis[J]. Retina, 2021, 41(2): 431-437.
|
| [30] |
Franzco HM, Franzco MC. Diagnostic vitreous biopsy in patients with uveitis: a useful investigation[J]. Clin Exp Ophthalmol, 2010, 33(6): 604-610.
|
| [31] |
陶勇. 眼内液病原学检测的研究进展[J]. 中华眼科杂志，2018，54(7)：551-556.
|
| [32] |
Kolomeyer AM, Murphy KM, Traband A, et al. Beta-D-glucan testing in patients with fungal endophthalmitis[J]. Retina, 2018, 38(4): 650-659.
|
| [33] |
Karageorgopoulos DE, Vouloumanou EK, Ntziora F, et al. Beta-D-glucan assay for the diagnosis of invasive fungal in-fections: a meta-analysis[J]. Clin Infect Dis, 2011, 52(6): 750-770.
|
| [34] |
Cornut PL, Boisset S, Romanet JP, et al. Principles and applica-tions of molecular biology techniques for the microbiological diagnosis of acute post-operative endophthalmitis[J]. Surv Ophthalmol, 2014, 59(3): 286-303.
|
| [35] |
Haseeb AA, Elhusseiny AM, Siddiqui MZ, et al. Fungal endophthalmitis: a comprehensive review[J]. J Fungi, 2021, 7(11): 996-1016.
|
| [36] |
范媛媛，魏文斌. 内源性眼内炎新进展[J]. 国际眼科纵览，2018，42(5): 329-337.
|
| [37] |
Hariprasad SM, Mieler WF. Antibiotics[J]. Dev Ophthalmol, 2015, 55: 344-356.
|
| [38] |
Kernt M, Neubauer AS, Kaspar HMD, et al. Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis[J]. Retina, 2009, 29(3): 362-370.
|
| [39] |
陈祖基. 眼科临床药理学[M]. 北京：化学工业出版社生物医药出版分社，2011：140-154.
|
| [40] |
杨丽娜，辛萌，吴祥根，等. 玻璃体腔注射伏立康唑缓释微球对兔烟曲霉菌性眼内炎的抗感染作用[J]. 药学学报，2010，45(6)：78-784.
|
| [41] |
Lightman S, Sallam A, Jayakumar S. Intraocular delivery of anti-infective drugs-bacterial, viral, fungal and parasitic[J]. Recent Pat Antiinfect Drug Discov, 2008, 3(1): 53-63.
|
| [42] |
Sato Y, Miyasaka S, Shimada H. Prognosis of endogenous fungal endophthalmitis and utility of Ishibashi′s classification[J]. Jpn J Ophthalmol, 2001, 45(2): 181-186.
|
| [43] |
William A, Spitzer MS, Deuter C, et al. Outcomes of primary transconjunctival 23-Gauge Vitrectomy in the diagnosis and treatment of presumed endogenous fungal endophthalmitis[J]. Ocul Immunol Inflamm, 2017, 25(2): 239-245.
|
| [44] |
Riddell JT, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents[J]. Clin Infect Dis, 2011, 52(5): 648-653.
|
| [45] |
Nagpal M, Jain P, Nagpal K. Pars plana vitrectomy with or without silicone oil endotamponade in surgical management of endophthalmitis[J]. Asia Pac J Ophthalmol (Phila), 2012, 1(6): 216-221.
|
| [46] |
陈倩茵，张静琳，林振德，等. 白内障摘除联合人工晶状体植入术后急性感染性眼内炎的临床观察[J/CD]. 中华眼科医学杂志(电子版)，2018，8(1)：9-14.
|
| [47] |
Behera UC, Budhwani M, Das T, et al. Role of early vitrectomy in the treatment of fungal endophthalmitis[J]. Retina, 2018, 38: 1385-1392.
|
| [48] |
Take B, Yashi H, Mizota A, et al. Relation between stage of endogenous fungal endophthalmitis and prognosis[J]. Graefes Arch Clin Exp Ophthalmol, 2006, 244(7): 816-820.
|
| [49] |
Hua Y, Li J. An experimental study on antimicrobial activity of silicone oil in vitro[J]. Ophthalmologica, 2008, 222(4): 245-248.
|
| [50] |
颜华，陈松，张静楷，等. 白内障术后眼内炎保留人工晶状体的治疗[J]. 中华眼科杂志，2009，45(8)：684-687.
|
| [51] |
Yoon KD, In MH, Geun JS, et al. Recent clinical manifestation and prognosis of fungal endophthalmitis: a 7-year experience at a tertiary referral center in Korea[J]. J Korean Med Sci, 2015, 30(7): 960-964.
|